Duos Technologies Group Reports First Quarter 2021 Results
ACCESSWIRE
JACKSONVILLE, FL / ACCESSWIRE / May 13, 2021 /
First Quarter 2021 and Recent Operational Highlights
Introduced obliquevue™ and additional perspectives to the Company s current Railcar Inspection Portals (rip®) solution. The obliquevue™ is the first of a new generation of AI-based inspection systems being developed by Duos as a part of its new rapid development initiative.
Elected rail industry veteran Ed Harris to the Board of Directors, who now serves as Chairman of the Company s Nominating and Governance Committees and also as a member of the Audit Committee.
First Quarter 2021 Financial Results
It should be noted that the following Financial Results represent the consolidation of the Company with its subsidiaries Duos Technologies, Inc. and
Dyadic Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress
ACCESSWIRE
Advancing Dyadic s proprietary COVID-19 vaccine candidate, DYAI-100, towards a first-in-human Phase 1 clinical trial
Goal of validating that C1 produced proteins are safe in humans and to accelerate adoption and use of C1 technology platform for the development and manufacture of vaccines and therapeutics
Goal of bringing larger quantities of lower cost COVID-19 vaccines that can be used as a prime and booster to existing vaccines
Engaged CR2O to manage and support further preclinical and clinical development
Initiated toxicology study
cGMP manufacturing run in progress
Collaborating on next-generation COVID-19 variant vaccines and/or boosters through Korea and Southeast Asia vaccine development partnership with Medytox (
Edesa Biotech Reports Fiscal 2nd Quarter 2021 Results
ACCESSWIRE
14 May 2021, 22:05 GMT+10
TORONTO, ON / ACCESSWIRE / May 14, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today reported financial results for the three and six months ended March 31, 2021 and provided an update on its business.
The company reported that it has enrolled more than 285 patients in an ongoing Phase 2/3 clinical study of its investigational drug, EB05, as a single-dose treatment for hospitalized COVID-19 patients with or at risk of developing Acute Respiratory Distress Syndrome (ARDS). ARDS is the leading cause of death in COVID-19 patients. The study is being funded in part by a C$14 million reimbursement grant from the Canadian Government. In addition, Edesa completed enrollment of the first cohort of a Phase 2b clinical study evaluating another drug candidate, EB01, as a monotherapy for chronic Allergic Conta
Gold Mountain Updates Mineral Resource Estimate at the Elk Gold Property
ACCESSWIRE
14 May 2021, 17:43 GMT+10
VANCOUVER, BC / ACCESSWIRE / May 14, 2021 / Gold Mountain Mining Corp. ( Gold Mountain or the Company ) (TSX.V:GMTN, OTCQB:GMTNF, Frankfurt: 5XFA) is pleased to announce an updated National Instrument 43-101 Mineral Resource Estimate following the conclusion of its Phase1 drill program at the Elk Gold Project. An updated technical report will be filed on the Company s website and SEDAR within 45 calendar days of this disclosure.
Highlights:
Gold Mountain increases its resource estimate at its flagship Elk Gold Project to:
651,000 oz of Measured & Indicated Resources at 6.1 g/t Au and 159,000 oz of Inferred resource at 4.8 g/t Au.
Cinedigm Announces Rapid Subscriber Growth and Expanding Independent Content Offering on Fandor
ACCESSWIRE
Cinedigm Reports 39% Subscriber Growth
on Fandor Following January 2021 Acquisition
LOS ANGELES, CA / ACCESSWIRE / May 14, 2021 /
Cinedigm (NASDAQ:CIDM), the leading independent streaming entertainment company super-serving enthusiast fan bases, announced today that the Company s SVOD streaming service,
Fandor, called The Netflix for Indie Film by The Wall Street Journal, is reporting significant growth in year-over-year monthly user subscriptions following regular increases to content offered on the Fandor Amazon Prime channel.
Since the Cinedigm acquisition in January 2021, Fandor has achieved 39% year-over-year subscriber growth on the Amazon Prime service in April. Fandor s rapid subscriber growth is augmented by the service s continuously expanding library of top-tier independent films, documentaries, and international titles.